TSX closed
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/TSX/MSCL

Satellos Bioscience Inc. (MSCL : TSX)

Common Stock

$13.08

CAD

+0.08 (0.62%)

Last updated: 2026-08-26

Get MSCL alerts:

MSCL

Satellos Bioscience Inc.

Source:WealthAwesomeWealthAwesome
$0.94 (7.74%)
30 day period
$11.72$13.05$14.38Jul 15Aug 6Aug 26

Performance

1 Day

+0.62%

1 Week

-5.35%

1 Month

-1.65%

YTD

+55.71%

Key Statistics

Market Cap

$275.81M

52W High

$18.98

52W Low

$7.08

P/E Ratio

-

50 Day MA

$11.97

200 Day MA

$11.03

Beta

1.17

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
8/26/2026$13.00$13.21$13.00$13.08$13.0818,974
8/25/2026$13.29$13.68$13.00$13.00$13.0012,695
8/24/2026$13.52$13.52$13.00$13.29$13.2918,714
8/21/2026$13.70$13.81$13.40$13.51$13.5117,929
8/20/2026$14.00$14.00$13.45$13.81$13.8121,038
8/19/2026$13.40$14.50$13.34$13.82$13.8215,204
8/18/2026$13.84$13.84$13.49$13.49$13.495,676
8/17/2026$13.36$13.80$13.36$13.60$13.606,730
8/14/2026$13.60$13.60$13.30$13.38$13.386,883
8/13/2026$13.90$14.00$13.78$13.85$13.853,113

Analyst Price Targets

Based on analyst covering MSCL

📈

Wall Street analysts forecast MSCL stock price to rise 35.1% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$17.67

+35.1% Upside

Current Price

C$13.08

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MSCL's historical volatility

HistoricalForecast68%95%
C$7.65C$12.46C$17.26C$22.06C$26.87C$31.67TodayApr 20Jun 23Aug 26Oct 8Nov 21Jan 3

30-Day Vol

56.6%

Annualized

90-Day Vol

74.2%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$15.64

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$13.88C$11.42C$16.87
60 trading daysC$14.73C$11.18C$19.42
90 trading daysC$15.64C$11.15C$21.93

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Satellos Bioscience Inc.

Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-35.82M
Profit Margin
0.00%
ROE (TTM)
-70.45%
EPS (Diluted)
-2.69
Book Value
3.96

🔄 Recent Splits

1-for-12

Jan 30, 2026

Reverse

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About MSCL

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
BNGBengal Energy Ltd$0.03+25.00%
KRNKarnalyte Resources Inc.$0.32+10.34%
FRXFennec Pharmaceuticals Inc$17.00+9.75%
BCTBriacell Therapeutics Corp$5.62+9.34%
YRBYorbeau Resources Inc$0.06+9.09%
PRUPerseus Mining Ltd$6.58+7.69%
CRDLCardiol Therapeutics Inc Class A$2.97+7.61%
SLTSaltire Capital Ltd.$2.70+7.57%

MSCL.TO news timeline

15 articles covering MSCL.TO, most recent first

Latest

Why Satellos Bioscience Inc. stock is gaining today

Stocks

Advertisement